Introduction
============

Brain tumors refer to all tumors in the central spinal canal or inside the cranium. All brain tumors are innately serious and fatal because of their infiltrative and invasive features in the confines of the intracranial cavity. According to the American Cancer Society, death estimation of Brain and other nervous system tumors is 6,150 (2%) per 100,000 in 2013. In 2013, 1310 cancer deaths amongst children between 0 to 14 years old were reported. Approximately, 25% of all cancers in children are due to brain and other central nervous system tumors ([@B1]-[@B3]) .

The human mitochondrial DNA (mtDNA) is a 16,569 base-pair-long double-strand DNA. Mitochondrial genome codes thirteen pivotal polypeptides of the respiratory chain enzyme complexes, which are located in the inner membrane of the mitochondria, along with two ribosomal RNAs (rRNAs) and twenty-two transfer RNAs (tRNAs) that are crucial for protein synthesis and intramitochondrial translation, respectively ([@B4]).

There are 10^3^ to 10^4^ copies of mtDNA per human cell ([@B5]). A 1.1 kb of noncoding displacement loop (D-loop) region is situated between the aforementioned genes. This region consists of heavy-strand and light-strand promoter regions which are essential for the mitochondrial transcription and replication process ([@B4], [@B6], [@B7]).

Due to insufficient DNA repair mechanisms, the absence of protective histone proteins, and a considerable level of the reactive oxygen species (ROS) production during oxidative phosphorylation (OXPHOS), mitochondrial DNA is susceptible to oxidative damage and carries significantly more mutations than nuclear DNA. In mtDNA, oxidative damages and the subsequent mutations can accumulate at a rate of 10-fold faster than nuclear DNA ([@B8]).

In the past, a myriad of somatic mtDNA mutations, including insertions, deletions, point mutations, and altered mtDNA copy numbers, have been detected in numerous human cancers ([@B9]). In the mitochondrial genome, some of these mutations lead to functional alterations in its encoded proteins or missense mRNA transcription ([@B10]). In the coding region, the common deletion region (CD) (4,977 bp deletion) is the most frequent ([@B11]). It has been shown that large deletions in the mitochondrial genome are accumulated in subjects with heteroplasmic mtDNA mutations and healthy elders ([@B12]).

The somatic variations in the D-loop area may be associated with the diminution of mtDNA copy numbers as well ([@B13]). The D-loop area of Mitochondrial DNA is a polymorphic region ([@B14]). The most of the mtDNA mutations occurring in D-loop are linked to human malignancies ([@B13]). Therefore, studying mtDNA mutations in various tumor cells is pivotal for understanding the relationship between mtDNA D-loop mutations and the initiation and progression of a tumor ([@B15]).

Materials and Methods
=====================

Subjects
--------

In this experimental study, 25 samples of brain tumors and adjacent tissues (2 women and 23 men in the age range of 28 to 70 years old) were collected ([Table 1](#T1){ref-type="table"}). Furthermore, 454 blood samples from healthy controls were included; these samples are from 100 random individuals, belonging to17 ethnicities of the Iranian population. All of the samples were collected from the Tehran Special Medical Center. Tumor tissues and adjacent ones were quickly frozen by liquid nitrogen and transferred to a -80˚C freezer. The cancer diagnosis was confirmed via histological analysis. In the control group, the exclusion criterion was metabolic diseases, history of cancer, and any mitochondrial DNA related diseases which might affect the mtDNA.

###### 

Age and histological features of brain tumors in patients

  -------- ----- --------------------------------------- ------------------------- --------
                                                                                   
  Sample   Age   Clinical data                           Diagnosis                 Gender
                                                                                   
  1        53    Left frontal brain tumor                Astrocytoma               Male
  2        53    Right fronto-temporal brain tumor       Giant Cell Glioblastoma   Male
  3        40    A right parieto-occipital brain tumor   Oligodendroglioma         Male
  4        48    Right temporal brain tumor              Astrocytoma               Male
  5        58    Left frontotemporal brain tumor         Astrocytoma               Male
  6        33    Intraventicular brain tumor             Ependymoma                Male
  7        56    Right temporal brain tumor              Astrocytoma               Male
  8        51    Right temporal brain tumor              Glioblastoma multiform    Male
  9        55    Left temporal brain tumor               Astrocytoma               Male
  10       57    Right frontoparietal brain tumor        Glioblastoma multiform    Male
  11       65    Left temporal brain tumor               Astrocytoma               Male
  12       42    Right parieto-occipital brain tumor     Oligodendroglioma         Male
  13       70    Right frontoparietal brain tumor        Glioblastoma multiform    Female
  14       54    Right frontal brain tumor               Glioblastoma multiform    Male
  15       58    A cerebral tumor                        Glioblastoma multiform    Male
  16       53    Right temporal brain tumor              Glioblastoma multiform    Male
  17       63    Right temporal brain tumor              Glioblastoma multiform    Male
  18       40    A cerebral tumor                        Glioblastoma multiform    Male
  19       28    Left frontal brain tumor                Glioblastoma multiform    Male
  20       55    A right frontoparietal brain tumor      Oligodendroglioma         Male
  21       63    Right frontal brain tumor               Glioblastoma multiform    Male
  22       32    Left frontal cerebral tumor             Glioblastoma multiform    Male
  23       32    Cerebral tumor                          Astrocytoma               Male
  24       56    Right temporal brain tumor              Astrocytoma               Female
  25       36    Left temporal brain tumor               Astrocytoma               Male
                                                                                   
  -------- ----- --------------------------------------- ------------------------- --------

DNA extraction
--------------

Genomic DNA of the tumor and the adjacent tissues were isolated by DNA extraction kit (Qiagen, Netherlands) and blood samples of the controls. which were collected in Ethylenediaminetetraacetic acid (EDTA)-containing tubes, were extracted using Diatom DNA extraction kit (Gene Fanavaran, Iran) and their quantity and quality were analyzed by NanoDrop 2000 UV-Vis Spectrophotometer (Thermo Fisher Scientific) and agarose gel electrophoresis, respectively.

Mitochondrial D-loop genotyping
-------------------------------

Primers for amplifying of the mtDNA D-loop region were adapted from Seyedhassani et al. ([@B16]) and Shakhssalim et al. ([@B17]).

The volume of a PCR reaction was 25 μl and contained 50- 100 ng of the DNA, 0.8 μl of the primers, 0.8 μl of MgCl2, 0.5 μl of dNTPs 10 mM, 2.5 μl of PCR buffer (10X), and 0.3 μl of Taq DNA polymerase (Roche Applied Sciences, Germany). Moreover, the PCR procedure was carried out according to the following protocol: pre-denaturation phase (5 minutes at 94˚C), followed by 35 cycles of the shorter denaturation phase (50 seconds at 94˚C), annealing step (50 seconds at 55˚C), the extension step (50 seconds at 72˚C), The final stage is the extension phase for 10 minutes at 72˚C. Each amplified fragment subsequently was sequenced using an ABI PRISM 3730 sequence analyzer (Macrogen, Korea). The acquired sequencing data were evaluated using Finch TV.

Statistical analysis
--------------------

Finch TV version 1.4.0 was used to edit and align the sequences. The NCBI blast was used as a reference. The statistical analysis was carried out using IBM SPSS statistics for windows, version 24.0 (IBM Corp., Armonk, NY, USA). The chi-square was used to evaluate the deviation from the Hardy-Weinberg equilibrium. This association between a brain tumor and D-loop variants was evaluated using SPSS version 22. A P\<0.05 was considered statistically significant

Results
=======

In the present study, tissue samples from 25 subjects with brain tumors and 454 blood samples from the control group were genotyped for D-loop region variants. The subsequent results showed 36 variations in the D-loop area ([Table 2](#T2){ref-type="table"}), most of which were already reported under MITOMAP. One hundred and fifteen variations of the D-loop region were found in the control groups ([Table 3](#T3){ref-type="table"}). However, 34 mutations in the patients and 103 mutations in the control were reported in advance, and 2 mutations in the patients and 12 mutations in the control were novel mutations ([Table 4](#T4){ref-type="table"}). All variations were single nucleotide substitutions and the majority of them were C→T. (33.33%) T→C (30.55%) G→A (22.22%) A→C (2.77%) C→G (2.77%). The D-loop region variant distributions in the controls and the patients are shown in Table S1 (See Supplementary Online Information at www. celljournal.org). The significant associations between variants and brain tumor risk (P\<0.05) are shown in Table 5.

###### 

List of D-loop region variants in the patient group (tissue sample)

  --------- --------- --------- --------- --------- --------- --------- --------- --------- -------------
                                                                                            
                                                                                            
  A152G     T195C     T204C     G207A     A263G     T489C     A750G     C15884G   G15928A   T15936C^\*^
  C16069T   T16126C   G16145A   C16148T   T16172C   C16186T   T16189C   C16193T   C16223T   T16224C
  C16234T   C16256T   C16261T   C16270T   G16274A   C16292T   T16311C   A16318C   C16327T   C16355T
  T16362C   G16384A   G16392A   G16394A   G16477A   T16519C                                 
                                                                                            
  --------- --------- --------- --------- --------- --------- --------- --------- --------- -------------

\*; Shows unreported mutations near the D-loop region.

###### 

List of D-loop region variants in control group (blood sample)

  --------- --------- ------------- ------------- ------------- ------------- --------- ------------- --------- -------------
                                                                                                                
                                                                                                                
  A152G     T195C     T204C         G207A         A263G         T489C         A750G     A15908G       T15924C   C15927T
  C15928T   G15946A   G16004C^\*^   A16017G       A16069G       G16071A       A16075G   C16084T       A16086G   A16087G^\*^
  A16093G   G16095A   G16114A       G16124A^\*^   A16126G       A16128G^\*^   C16129T   G16131A^\*^   C16145T   G16148A
  C16149T   G16150A   T16162C       T16163C       A16172G       G16174A       G16176A   A16177G       A16179G   G16184A
  G16186A   C16187T   A16189G       G16192A       G16193A       G16197A       G16201A   T16203C       A16209G   A16217G
  A16223G   G16233A   G16236A       G16242A       A16243G       G16245A       A16248G   A16249G       G16256A   G16257A
  G16259A   G16261A   G16262A       T16265C       C16266T       G16270A       A16271G   A16272G       C16274T   G16278A
  A16286G   G16287A   A16289G       G16290A       G16291A       G16292A       T16293G   G16294A       G16295A   G16296A
  A16299G   A16304G   T16309C       A16311G       G16315A^\*^   T16316C       T16318A   C16319T       A16323G   A16325G
  A16334G   C16339T   A16342G       T16343C       A16344G^\*^   A16352G       G16354T   G16355A       A16356G   A16359G
  G16360A   A16362G   G16364A       C16390T       C16391T       C16398T       T16399C   A16468G       G16478C   G16481A^\*^
  G16488A   T16497C   T16519C       C16526T       G16527A                                                       
                                                                                                                
  --------- --------- ------------- ------------- ------------- ------------- --------- ------------- --------- -------------

\*; Shows unreported variations in D-loop region and adjacent sequences.

###### 

List of unreported variants in patient and control groups

  --------- --------- --------- --------- --------- --------- --------- --------- --------- ---------
                                                                                            
                                                                                            
  A15499G   G16004C   A16087G   G16124A   A16128G   G16131A   A16179G   G16233A   A16286G   G16315A
  A16344G   G16481A                                                                          
                                                                                            
  --------- --------- --------- --------- --------- --------- --------- --------- --------- ---------

###### 

The variations statistical analysis and associations between them whit brain tumour risk

  ------------ ------------------ --------- ------------- -------------- ---------
                                                                         
  Odds ratio   Chi-square tests   P value   Control (%)   Patients (%)   Variant
                                                                         
  0.94         6.186^a^           0.013     0             6.25           T15936C
  0.94         6.186^a^           0.013     0             6.25           C15884G
  1            0.000^a^           1         6.38          6.25           G15928A
  2.048        3.854^a^           0.049     13.87         25             C16069T
  2.226        7.490^a^           0.006     30.83         50             T16126C
  1.57         1.339^a^           0.247     12.99         18.75          G16145A
  1.532        0.421^a^           0.516     3.96          6.25           C16148T
  1.532        0.421^a^           0.516     4.18          6.25           T16172C
  3.586        5.207^a^           0.022     3.52          12.5           C16186T
  0.457        4.190^a^           0.041     22.9          12.5           T16189C
  6.319        3.701^a^           0.045     1.32          6.25           C16193T
  0.318        10.351^a^          0.001     31.71         12.5           C16223T
  0.94         6.186^a^           0.013     0.22          6.25           T16224C
  0.94         6.186^a^           0.013     0.88          6.25           C16234T
  1.532        0.421^a^           0.516     4.4           6.25           C16256T
  1.898        2.510^a^           0.113     10.57         18.75          C16261T
  2.064        1.047^a^           0.306     2.6           6.25           C16270T
  4.831        6.793^a^           0.009     2.86          12.5           G16274A
  2.064        1.047^a^           0.306     2.64          6.25           C16292T
  0.362        4.310^a^           0.038     14.75         6.25           T16311C
  1.213        0.96^a^            0.756     4.62          6.25           A16318C
  6.319        3.701^a^           0.045     0.66          6.25           C16327T
  7.322        8.721^a^           0.003     2.2           12.5           C16355T
  6.682        7.680^a^           0.006     9.25          18.75          T16362C
  2.372        4.153^a^           0.042     0             6.25           G16384A
  0.94         6.186^a^           0.013     0.22          6.25           G16392A
  0.94         6.186^a^           0.013     0             6.25           G16394A
  0.94         6.186^a^           0.013     0             6.25           G16477A
  0.747        1.017^a^           0.313     62.55         56.25          T16519C
  1.047        0.023^a^           0.87      30.8          32             A152G
  0.5          2.94^a^            0.08      21.4          12             T195C
  1.37         0.47^a^            0.48      9.3           12             T204C
  1.81         1.45^a^            0.22      7             12             G207A
  0            0                  0         100           100            A263G
  1.34         0.741^a^           0.38      19.1          24             T489C
  0.39         3.979^a^           0.046     93.3          84             A750G
                                                                         
  ------------ ------------------ --------- ------------- -------------- ---------

^a^; 0 blocks (0.0%) have considered rate less than 5. The minimum envisaged rate is 31.50.

Discussion
==========

Studies have shown that the accumulation of mitochondrial DNA variations and mitochondrial instability contributes to several diseases, including cancer. The mitochondrial D-loop area has pivotal functions in transcription, replication, and mtDNA organization. Presence of two critical factors makes mitochondrial genome prone to different mutations: ROS and low-level of DNA repair system in mitochondria ([@B18]). However, the D-loop region is even more susceptible to the mutations than the rest of the human mitochondrial genome ([@B12]).

It has been demonstrated that the expansion of poly-C repeats in highly variable regions (HVR), adjacent to the D-loop and tRNA phenylalanine, increases the copy number; homoplasmy and loss of mitochondrial heteroplasmy act like cancer suppressor genes and will cause brain cancer and other cancers in humans ([@B19]).

Recent studies demonstrate that mitochondrial D-loop mutations play an important role in Huntington's disease ([@B20]), as well as various cancers, including brain tumors. Consequently, in this survey was hypothesised that particular mutations in the D-loop region might be related with brain tumor risk.

Twenty-five tissue samples of brain tumors were assessed. As it is not possible to use brain tissues of healthy individuals, we used 454 blood samples as the control. A significant difference between the cancer tissue and the healthy tissue was observed. Also, we studied the mutations reported in MITOMAP in more detail.

It has been proven that D-loop variants are associated with different disease: T195C variant with glaucoma ([@B21]) and G15884C variant with pancreatic cancer ([@B22]) and G15928A with MS, recurrent idiopathic abortion and AD ([@B23]) and C16069T with bladder cancer ([@B24]) and T16126C with Huntington's disease ([@B20]) and C16172T with head and neck cancer ([@B25]) and T16189C with prostate cancer ([@B26]) and C16193T with ovarian cancer ([@B27]) and C16223T with cancer, and Huntington's ([@B20]) and G16274A linked to prostate cancer ([@B28]) and C16292T related with breast and ovarian cancer ([@B27]) and T16311C with prostate cancer ([@B28]) and T16519C with glioblastoma, migraines ([@B29]). Although T204C ([@B30]), G207A ([@B28]), A263G ([@B31]), T489C ([@B25]), A750G ([@B21]), G16145A ([@B16]), C16148T ([@B32]), C16186T ([@B33]), T16224C, C16234T, C16256T ([@B34]), C16270T, C16261T ([@B35], [@B36]), C16327T ([@B37]), C16355T ([@B38]), T16362C ([@B39]), G16384A ([@B16]), G16392A, G16394A, G16477A ([@B40]), were associated with various cancers and were reported in MITOMAP but they were not associated with the disease.

In this experimental study, A750G, T15936C, C15884G, C16069T, T16126C, C16186T, T16189C, C16193T, C16223T, T16224C, C16234T, G16274A, T16311C, C16327T, C16355T, T16362C, G16384A, G16392A, G16394A, G16477A variants had statistically significant different frequencies between patient and control groups. Thus, it seems that they are associated with brain tumors. Among the mentioned polymorphisms, C16069T, T16126C, C16186T, G16274A, C16355T, and T16362C had a greater odd ratio (OR) than the rest. C16355T polymorphism had the most significant association with the disease in risk.

It should be noted that A152G, T204C, G207A, A263G, T489C, A750G, G15928A, G16145A, C16148T, T16172C, C16256T, C16261T, C16270T, C16292T, A16318C, and T16519C polymorphisms were not associated with the disease risk. Although, they have significant roles in other disease pathogenesis as they have been reported on MIT OMAP.

In Lorr ethnicity, T15936C, C15884G, G15928A, T16126C, C16148T, T16172C, C16186T, C16186T, C16193T, C16223T, T16224C, C16234T, C16256T, C16292T, T16311C, T16362C, G16384A, G16392A, G16394A, and G16477A polymorphisms were associated with brain tumors. T16126C and T16362C polymorphisms had a higher odds ratio than the rest which indicates they are more associated with this disease.

C16069T, G16145A, T16189C, C16261T, C16270T, A16318C, C16327T, and T16519C polymorphisms were not associated with the disease in Lorr ethnicity. However, the mentioned polymorphisms are associated with other disease pathogenesis as they reported on MITOMAP.

In Fars ethnicity, T15936C, C15884G , C16069T, T16126C, C16193T, T16224C, C16234T, C16261T, C16292T, C16327T, C16355T, G16384A, G16392A,G16394A, and G16477A variants were associated with the disease, C16069T, T16126C, C16186T, G16274A, C16355T, and T16362C polymorphisms had greater odds ratio than the rest, and G15928A, G16145A, C16148T, T16172C, C16186T, T16189C, C16223T, C16256T, C16270T, G16274A, T16311C, A16318C, T16362C, and T16519C variants were not associated with the disease.

Conclusion
==========

Base on the odds ratio result, C16069T, T16126C, C16186T, G16274A, C16355T, and T16362C alterations were significantly associated with brain tumor. Among these variants, C16355T with odds ratio 7.322 was the strongest one.
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